Hims & Hers Health Faces Securities Fraud Class Action Lawsuit

Key Facts

1Hims & Hers Health is facing a securities class action lawsuit following a federal complaint by the FTC alleging business misconduct.

Hims & Hers Health is facing a securities class action lawsuit following a federal complaint by the Federal Trade Commission (FTC) alleging business misconduct. PR Newswire reported that the lawsuit targets the company and its executives over claims of sharing consumer health information with third-party advertising platforms and charging for prescriptions before medical consultations occurred.

HIMS closed at $29.67 on October 5, 2026, with a session high of $30.04 and a low of $28.8. The legal escalation follows the FTC complaint which suggested the company could face heightened regulatory scrutiny and potential penalties, impacting investor sentiment and valuation.